Ptc Therapeutics (PTCT) Other financing activities (2023)
Ptc Therapeutics (PTCT) recorded quarterly Other financing activities of $85000.0 in Q3 2023, up 466.67% quarter-over-quarter from $15000.0 in Q2 2023.
Ptc Therapeutics (PTCT) Other financing activities (2023) Analysis & Trends
Ptc Therapeutics' Other financing activities history runs 1 years deep, the most recent figure standing at $85000.0 for Q3 2023.
- In Q3 2023, Other financing activities changed N/A year-over-year to $85000.0; the TTM figure through Dec 2023 stood at $282000.0 (changed N/A YoY), while the FY2023 annual figure was $282000.0, down 97.54% from the prior year.
- Other financing activities was $85000.0 for Q3 2023 at Ptc Therapeutics, up from $15000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $182000.0 in Q1 2023 to a low of $15000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 85,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Mar 31, 2023 | 182,000.00 |